Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to -$201000.0.

  • CG Oncology's Amortizatization of Intangibles fell 11270.54% to -$201000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $710000.0, marking a year-over-year decrease of 9079.48%. This contributed to the annual value of $5.0 million for FY2024, which is 7363.48% up from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Amortizatization of Intangibles is -$201000.0, which was down 11270.54% from $1.9 million recorded in Q2 2025.
  • CG Oncology's 5-year Amortizatization of Intangibles high stood at $2.5 million for Q2 2024, and its period low was -$1.3 million during Q4 2024.
  • For the 3-year period, CG Oncology's Amortizatization of Intangibles averaged around $1.1 million, with its median value being $1.5 million (2023).
  • Over the last 5 years, CG Oncology's Amortizatization of Intangibles had its largest YoY gain of 3732.64% in 2024, and its largest YoY loss of 18560.71% in 2024.
  • CG Oncology's Amortizatization of Intangibles (Quarter) stood at $1.5 million in 2023, then crashed by 185.61% to -$1.3 million in 2024, then surged by 83.98% to -$201000.0 in 2025.
  • Its Amortizatization of Intangibles was -$201000.0 in Q3 2025, compared to $1.9 million in Q2 2025 and $279000.0 in Q1 2025.